Rubicon Research Limited (NSE:RUBICON)
India · Delayed Price · Currency is INR 967.90
-9.85 (-1.01%)
At close: May 27, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 159.46 billion as of May 27, 2026.
Market Cap
159.46B
Enterprise Value
163.62B
Revenue
15.98B
Ranking
n/a
PE Ratio
74.25
Stock Price
967.90
Market Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 159.46B, an increase of 54.08%. That is a compound annual growth rate of 103.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 161.08B | 43.63% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 389.65B |
| J. B. Chemicals & Pharmaceuticals | 357.48B |
| AstraZeneca Pharma India | 219.89B |
| Granules India | 187.87B |
| Jubilant Pharmova | 159.52B |
| Caplin Point Laboratories | 157.74B |
| Viyash Scientific | 113.76B |
| CORONA Remedies | 104.05B |